|
|
|
 |
Stock Report | Snapshot
|
|
|
|
|
Dishman Pharma & Chem
|
|
|
|
| Snapshot |
|
|
|
|
Latest Closing Price
(17/05/2013)
(Rs)
|
|
72.50
|
|
|
Face Value (Rs)
|
|
2.00
|
|
|
Incorporation Year
|
|
(NA)
|
|
|
Daily High (Rs)
|
|
74.35
|
|
|
Daily Low (Rs)
|
|
72.10
|
|
|
52 Week High (Rs)
|
|
124.50
|
|
|
52 Week Low (Rs)
|
|
45.10
|
|
|
|
|
| Profile |
|
|
|
| Sector |
|
Chemicals
|
|
| Industry |
|
Inorganic Chem.
|
|
|
Market Cap. (Rs cr.)
|
|
595
|
|
|
PE Ratio
|
|
12.28
|
|
| PB Ratio |
|
0.85
|
|
| Year to Date Return(%) |
|
-37.23
|
|
|
|
| Funds That Own Dishman Pharma & Chem |
|
|
Fund Name
|
% Net Asset
|
Date
|
|
 |
|
BNP Paribas Midcap Direct
|
0.71
|
Apr 30, 2013
|
|
|
|
BNP Paribas Midcap
|
0.71
|
Apr 30, 2013
|
|
|
|
BNP Paribas Dividend Yield
|
0.70
|
Apr 30, 2013
|
|
|
|
BNP Paribas Dividend Yield Direct
|
0.70
|
Apr 30, 2013
|
|
|
|
HDFC Mid-Cap Opportunities Direct
|
0.50
|
Apr 30, 2013
|
|
|
|
HDFC Mid-Cap Opportunities
|
0.50
|
Apr 30, 2013
|
|
|
|
Canara Robeco Emerging Equities Regular
|
0.41
|
Apr 30, 2013
|
|
|
|
BNP Paribas Tax Advantage Direct
|
0.41
|
Apr 30, 2013
|
|
|
|
BNP Paribas Tax Advantage Plan
|
0.41
|
Apr 30, 2013
|
|
|
|
Canara Robeco Emerging Equities Regular Direct
|
0.41
|
Apr 30, 2013
|
|
|
|
UTI Pharma & Healthcare
|
0.36
|
Apr 30, 2013
|
|
|
|
UTI Pharma & Healthcare Direct
|
0.36
|
Apr 30, 2013
|
|
|
|
HDFC Taxsaver
|
0.09
|
Apr 30, 2013
|
|
|
|
HDFC Taxsaver Direct
|
0.09
|
Apr 30, 2013
|
|
|
|
Goldman Sachs CNX 500 Direct
|
0.01
|
Apr 30, 2013
|
|
|
|
Goldman Sachs CNX 500
|
0.01
|
Apr 30, 2013
|
|
|
|
View All Funds that Own Dishman Pharma & Chem
|
|
|
